Post-IPO Equity Pharmaceutical Companies

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

A health sciences company that develops innovative options for preventive and curative therapies .

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Forte Biosciences is a biotechnology company that focuses on dermatology.

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.